BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Small BG, Wendt B, Jamei M, Johnson TN. Prediction of liver volume - a population-based approach to meta-analysis of paediatric, adult and geriatric populations - an update. Biopharm Drug Dispos 2017;38:290-300. [PMID: 28084034 DOI: 10.1002/bdd.2063] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Dai HR, Liu Y, Lu KY, He X, Guo HL, Hu YH, Xu J, Ding XS, Chen F, Cheng R, Jiao Z. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms. Pharmacol Res 2022;184:106416. [PMID: 36029933 DOI: 10.1016/j.phrs.2022.106416] [Reference Citation Analysis]
2 Cassese G, Han H, Lee B, Lee HW, Cho JY, Troisi R. Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma. Cancers 2022;14:2012. [DOI: 10.3390/cancers14082012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sjöstedt N, Adiwidjaja J, Murphy WA, Brouwer KL. DRUG TRANSPORT IN THE LIVER. Drug Transporters 2022. [DOI: 10.1002/9781119739883.ch13] [Reference Citation Analysis]
4 Jansen AME, Muilwijk EW, Van Der Velden WJFM, Maertens JA, Aerts R, Colbers A, Burger D, Verweij PE, Heine RT, Blijlevens NMA, Brüggemann RJM. Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis. Clin Microbiol Infect 2022:S1198-743X(22)00053-2. [PMID: 35150880 DOI: 10.1016/j.cmi.2022.01.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Puttrevu SK, Arora S, Polak S, Patel NK. Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations. Pharmaceutics 2020;12:E942. [PMID: 33008144 DOI: 10.3390/pharmaceutics12100942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
6 Writers AM. Dosage adjustment in obese children, even for common drugs, is largely unclear and a treat-to-effect approach may work best. Drugs Ther Perspect 2020;36:341-346. [DOI: 10.1007/s40267-020-00734-w] [Reference Citation Analysis]
7 Adiwidjaja J, Boddy AV, McLachlan AJ. Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics. Front Pharmacol 2019;10:1672. [PMID: 32082165 DOI: 10.3389/fphar.2019.01672] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
8 Kyler KE, Wagner J, Hosey-Cojocari C, Watt K, Shakhnovich V. Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children. Paediatr Drugs 2019;21:357-69. [PMID: 31432433 DOI: 10.1007/s40272-019-00352-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
9 Badhan RK, Gittins R, Al Zabit D. The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study. Drug and Alcohol Dependence 2019;200:168-80. [DOI: 10.1016/j.drugalcdep.2019.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Guiastrennec B, Sonne DP, Bergstrand M, Vilsbøll T, Knop FK, Karlsson MO. Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans. CPT Pharmacometrics Syst Pharmacol 2018;7:603-12. [PMID: 30070437 DOI: 10.1002/psp4.12325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 Badhan R, Zakaria Z, Olafuyi O. The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options. Journal of Pharmaceutical Sciences 2018;107:2236-50. [DOI: 10.1016/j.xphs.2018.03.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ter Heine R, van Erp NP, Guchelaar HJ, de Fijter JW, Reinders MEJ, van Herpen CM, Burger DM, Moes DJAR. A pharmacological rationale for improved everolimus dosing in oncology and transplant patients. Br J Clin Pharmacol 2018;84:1575-86. [PMID: 29574974 DOI: 10.1111/bcp.13591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Olafuyi O, Coleman M, Badhan RKS. Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: A case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin. Eur J Pharm Sci 2017;106:20-33. [PMID: 28546104 DOI: 10.1016/j.ejps.2017.05.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]